- Home
- RLAY vs PRIM Comparison
RLAY vs PRIM Comparison
Compare RLAY & PRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | PRIM |
|---|---|---|
| Founded | 2015 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Water Sewer Pipeline Comm & Power Line Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.4B |
| IPO Year | 2020 | 2006 |
Fundamental Metrics
Financial Performance| Metric | RLAY | PRIM |
|---|---|---|
| Price | $18.41 | $65.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | $27.58 | ★ $115.13 |
| AVG Volume (30 Days) | ★ 2.4M | 1.5M |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $60.15 | $11.71 |
| P/E Ratio | ★ N/A | $83.48 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $5.95 | $62.41 |
| 52 Week High | $21.27 | $205.50 |
Technical Indicators
Market Signals| Indicator | RLAY | PRIM |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 42.31 |
| Support Level | $17.45 | $63.70 |
| Resistance Level | $20.31 | $84.46 |
| Average True Range (ATR) | 1.15 | 5.31 |
| MACD | -0.04 | -0.73 |
| Stochastic Oscillator | 44.29 | 28.75 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About PRIM Primoris Services Corporation
Primoris Services Corp is a provider of critical infrastructure services operating mainly in the United States and Canada. The company provides a range of construction, maintenance, replacement, and engineering services. The Utilities segment operates throughout the United States and specializes in a range of services, including the construction and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communications systems. The Energy segment operates throughout the United States and Canada and specializes in a range of services that include engineering, procurement, construction, and maintenance services to various industries. The majority of the company's revenue is derived from the Energy segment.